Soleus Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.47M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $2.67M | Buy |
|
|||||
|
2023
Q3 | $1.78M | Sell |
|
|||||
|
2023
Q2 | $2.54M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.5M | Sell |
|
|||||
|
2022
Q3 | $3.49M | Buy |
|
|||||
|
2022
Q2 | $2.28M | Sell |
|
|||||
|
2022
Q1 | $5.8M | Sell |
|
|||||
|
2021
Q4 | $11.8M | Buy |
|
|||||
|
2021
Q3 | $3.3M | Sell |
|
|||||
|
2021
Q2 | $4.35M | Sell |
|
|||||
|
2021
Q1 | $12.7M | Buy |
|
|||||
|
2020
Q4 | $8.58M | Buy |
|
|||||
|
2020
Q3 | $5.54M | Buy |
|
|||||
|
2020
Q2 | $3.15M | Buy |
|
|||||
|
2020
Q1 | $150K | Sell |
|
|||||
|
2019
Q4 | $2.12M | Buy |
|